These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17484224)

  • 1. Macrolide resistance and emm type distribution of invasive pediatric group A streptococcal isolates: three-year prospective surveillance from a children's hospital.
    Jaggi P; Beall B; Rippe J; Tanz RR; Shulman ST
    Pediatr Infect Dis J; 2007 Mar; 26(3):253-5. PubMed ID: 17484224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan.
    Chuang PK; Wang SM; Lin HC; Cho YH; Ma YJ; Ho TS; Shen CF; Liu CC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):160-7. PubMed ID: 24094501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
    Michos A; Koutouzi FI; Tsakris A; Chatzichristou P; Koutouzis EI; Daikos GL; Stathi A; Syriopoulou VP
    J Antimicrob Chemother; 2016 Aug; 71(8):2113-7. PubMed ID: 27118782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. emm Types and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece during 2011-2017.
    Grivea IN; Syrogiannopoulos GA; Michoula AN; Gazeti G; Malli E; Tsilipounidaki K; Fouzas S; Anthracopoulos MB; Petinaki E
    PLoS One; 2020; 15(5):e0232777. PubMed ID: 32379802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.
    Green M; Martin JM; Barbadora KA; Beall B; Wald ER
    Antimicrob Agents Chemother; 2004 Feb; 48(2):473-6. PubMed ID: 14742197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
    Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-based surveillance in the united states of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons.
    Tanz RR; Shulman ST; Shortridge VD; Kabat W; Kabat K; Cederlund E; Rippe J; Beyer J; Doktor S; Beall BW;
    Clin Infect Dis; 2004 Dec; 39(12):1794-801. PubMed ID: 15578402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.
    Syrogiannopoulos GA; Grivea IN; Al-Lahham A; Panagiotou M; Tsantouli AG; Michoula Ralf René Reinert AN; van der Linden M
    PLoS One; 2013; 8(8):e71558. PubMed ID: 23977078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.
    Dundar D; Sayan M; Tamer GS
    Microb Drug Resist; 2010 Dec; 16(4):279-84. PubMed ID: 20624096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates.
    Muhtarova A; Mihova K; Markovska R; Mitov I; Kaneva R; Gergova R
    Acta Microbiol Immunol Hung; 2019 Dec; 67(1):14-17. PubMed ID: 31833385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia.
    Ksia S; Smaoui H; Hraoui M; Bouafsoun A; Boutiba-Ben Boubaker I; Kechrid A
    Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
    Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.
    Montes M; Tamayo E; Mojica C; García-Arenzana JM; Esnal O; Pérez-Trallero E
    J Antimicrob Chemother; 2014 Jun; 69(6):1474-82. PubMed ID: 24562616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
    Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
    J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
    Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
    Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in macrolide-resistant Streptococcus pyogenes isolates from French children.
    d'Humières C; Cohen R; Levy C; Bidet P; Thollot F; Wollner A; Bingen E
    Int J Med Microbiol; 2012 Dec; 302(7-8):300-3. PubMed ID: 23103047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Declining macrolide resistance in Streptococcus pyogenes in Portugal (2007-13) was accompanied by continuous clonal changes.
    Silva-Costa C; Ramirez M; Melo-Cristino J;
    J Antimicrob Chemother; 2015 Oct; 70(10):2729-33. PubMed ID: 26142474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of macrolide resistant Streptococcus pyogenes isolates from pharyngitis patients in Serbia.
    Opavski N; Gajic I; Borek AL; Obszańska K; Stanojevic M; Lazarevic I; Ranin L; Sitkiewicz I; Mijac V
    Infect Genet Evol; 2015 Jul; 33():246-52. PubMed ID: 25976381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
    Shulman ST; Tanz RR; Dale JB; Beall B; Kabat W; Kabat K; Cederlund E; Patel D; Rippe J; Li Z; Sakota V;
    Clin Infect Dis; 2009 Jul; 49(1):78-84. PubMed ID: 19480575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.